Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “ras”

843 pharma patents match "ras" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 843
Index total 30,257
Page 25 / 36

Quick answer

This filtered view shows 843 pharmaceutical patents matching "ras" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

843 results for “ras” · 30,257 patents in full index Clear search

  1. US 8163960

    Process for preparing and drying solid rasagiline base

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  2. US 8158627

    Compositions and treatments using pyridazine compounds and cholinesterase inhibitors

    Northwestern University · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted
  3. US 8153644

    Diacylglycerol acyltransferase inhibitors

    Madrigal Pharmaceuticals, Inc. · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted
  4. US 8153609

    Purine nucleotide derivatives

    Lauras AS · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted
  5. US 8148378

    Pyridazine derivatives and their use as inhibitors of stearoyl-CoA desaturase-1 activity in a mammal

    Xenon Pharmaceuticals Inc. · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  6. US 8147845

    Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

    ONCOLYTICS BIOTECH INC. · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  7. US 8124766

    Inhibitors of diacylglycerol acyltransferase

    Madrigal Pharmaceuticals, Inc. · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted
  8. US 8115011

    Diacylglycerol acyltransferase inhibitors

    Madrigal Pharmaceuticals, Inc. · Granted Feb 14, 2012 · Expires Feb 9, 2032

    granted
  9. US 8093274

    Inhibitors of protein prenyltransferases

    The Regents of the University of California · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  10. US 8092838

    Use of hydrogen sulfide in the treatment of eye diseases

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  11. US 8088760

    Benzoxazole carboxamide inhibitors of poly(ADP-ribose)polymerase (PARP)

    BIOMARIN PHARMACEUTICAL INC. · Granted Jan 3, 2012 · Expires Dec 29, 2031

    granted
  12. US 8080584

    Delayed release rasagiline citrate formulation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted
  13. US 8071603

    Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors

    Xenon Pharmaceuticals Inc. · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  14. US 8067473

    Methods for enhancing the therapeutic efficacy of topoisomerase inhibitors

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  15. US 8067606

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  16. US 8048906

    Optically pure and enriched isomers of chelating ligands and contrast agents

    Catalyst Medical · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted
  17. US 8049016

    Thiazole derivatives which inhibit stearoyl-CoA desaturase enzymes

    Xenon Pharmaceuticals Inc. · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted
  18. US 8039257

    Pre-transplant accomodated organs resistant to anti-donor immunity

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted
  19. US 8034556

    Regulation of glucose and insulin levels by GnT-4 glycosyltransferase activity

    The Regents of the University of California · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted
  20. US 8034832

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted
  21. US 8030488

    Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted
  22. US 8026360

    Substituted pyridazines as stearoyl-CoA desaturase inhibitors

    Xenon Pharmaceuticals Inc. · Granted Sep 27, 2011 · Expires Sep 22, 2031

    granted
  23. US 8025887

    Avirulent, immunogenic flavivirus chimeras

    The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Sep 27, 2011 · Expires Sep 22, 2031

    granted
  24. US 8021646

    Compositions and methods for magnetic resonance imaging contrast agents

    Northwestern University · Granted Sep 20, 2011 · Expires Sep 15, 2031

    granted